Pathogenesis of paroxysmal nocturnal hemoglobinuria

Area of Science:

• Hematology
• Immunology
• Genetics

Background:

• Paroxysmal nocturnal hemoglobinuria (PNH) is a non-malignant clonal hematopoietic disorder.
• PNH pathogenesis involves a mutant stem cell with PIGA gene mutation and clonal expansion.
• The mechanisms driving clonal expansion are not fully understood.

Purpose of the Study:

• To elucidate the mechanisms underlying clonal expansion in Paroxysmal nocturnal hemoglobinuria (PNH).
• To investigate the role of autoimmune attack in PNH pathogenesis.
• To explore the relationship between PNH and aplastic anemia (AA).

Main Methods:

• Review of existing evidence supporting T cell-mediated autoimmune attack.
• Analysis of PIGA mutant microclones in normal individuals.
• Examination of outcomes in syngeneic bone marrow transplantation for PNH.
• Investigation of mouse models with targeted piga inactivation.
• Assessment of T cell activity in PNH and AA patients.

Main Results:

• PIGA mutations are consistently found in PNH stem cells.
• Clonal expansion in most PNH cases is not driven by secondary mutations.
• Evidence suggests T cell-mediated autoimmune attack against non-mutant stem cells promotes expansion of GPI-negative (PIGA mutant) stem cells.
• PNH shares pathogenetic links with aplastic anemia (AA).

Conclusions:

• PNH pathogenesis follows a Darwinian model involving somatic mutation and a specific selective environment.
• T cell-mediated autoimmunity plays a critical role in the clonal expansion of PIGA-mutant stem cells in PNH.
• Understanding PNH pathogenesis offers insights into aplastic anemia.